Related Experiment Video
Updated: Oct 1, 2026

Programmed Electrical Stimulation in Mice
Published on: May 26, 2010
Abrupt and sustained shortening of the AV delay of a DDDR pacemaker during stable sinus rhythm
1Florida Cardiovascular Institute and Tampa General Hospital, Tampa, FL, USA. ssbarold@aol.com
Abstract:
This article describes the abrupt and sustained shortening of the sensed AV delay in a patient with an Intermedics Marathon DDDR pacemaker programmed to the SmarTracking function, which prevents tracking of inappropriate atrial rates. The AV delay remained extended and stable when the sinus cycle became equal to the prevailing upper rate interval determined by sensor input. When the sinus rate remained stable, the AV delay returned abruptly to its shorter programmed duration at the end of the tachycardia terminating algorithm and remained constant afterwards. This behavior is caused by a pacemaker Wenckebach upper rate response related to the slow prevailing upper rate at rest provided by sensor input to the SmarTracking function of the pulse generator.
More Related Videos
08:05Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...